Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2022-38714

17
FAUCET Score

CVE-2022-38714 describes a sensitive credential disclosure vulnerability in IBM DataStage on Cloud Pak for Data versions 4.0.6 through 4.5.2. A highly privileged attacker can read stored credential information, leading to a high impact on confidentiality. The vulnerability has a CVSS score of 4.9 (MEDIUM) due to its network attack vector and high privileges required. There is currently no evidence of active exploitation, public exploit code, or significant community discussion surrounding this CVE.

Impacted Technologies

VendorProductVersion(s)CPE
Range not provided by sourceCPE matchmatch criteria
cpe:2.3:a:ibm:datastage:-:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

4.9MEDIUM

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:N

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
HIGH
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
NONE
Availability Impact
NONE
Exploitability Score
1.2
Impact Score
3.6
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.59%
Probability of exploitation in next 30 days
EPSS Percentile
44.6%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0059 is in the 44th percentile among its peer group of 3,563 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.1 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

exchange.xforce.ibmcloud.com / vulnerabilities/235060
VDB EntryVendor Advisory
ibm.com / support/pages/node/6618039
Vendor Advisory